In breast cancer CSCs, p53 inactivation was associated with constitutive MYC expression, which increases the frequency of symmetric division of CSCs, as revealed by the expression of a large number of mitotic genes useful to identify high-risk patients [58,59]. The gene discussed is MYC; the disease is breast cancer.